α-Glucosidase-IN-46
α-Glucosidase-IN-46 is a potent α-glucosidase inhibitor with an IC50 of 26.0 μM. α-Glucosidase-IN-46 can be used for the research of type 2 diabetes[1].
Product Specifications
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-46.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=C(CC)C=C1)COC2=CC=C(/C=N/NC(C3=CC(C4=CC=C(OC)C=C4)=NC5=CC=CC=C35)=O)C=C2OC
Molecular Formula
C35H32N4O5
Molecular Weight
588.65
References & Citations
[1]Hamedifar H, et al. Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies. Sci Rep. 2024 Jan 3;14 (1) :388.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
124672-HRP 100 µL
CD69 (Activation Inducer Molecule, AIM, BLAC/P26, CLEC2C, EA1, Early Activation Antigen CD69, Early T cell Activation Antigen p60, GP32/28, Leu23, MLR-3) (HRP)
Sign In for Pricing
View Details 
